nodes	percent_of_prediction	percent_of_DWPC	metapath
Apomorphine—DRD1—nerve—acquired immunodeficiency syndrome	0.0114	0.0553	CbGeAlD
Apomorphine—CALY—spinal cord—acquired immunodeficiency syndrome	0.00789	0.0382	CbGeAlD
Apomorphine—DRD2—nerve—acquired immunodeficiency syndrome	0.00676	0.0327	CbGeAlD
Apomorphine—CALY—nervous system—acquired immunodeficiency syndrome	0.00665	0.0322	CbGeAlD
Apomorphine—CALY—central nervous system—acquired immunodeficiency syndrome	0.0064	0.031	CbGeAlD
Apomorphine—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.00566	0.0274	CbGeAlD
Apomorphine—CALY—brain—acquired immunodeficiency syndrome	0.00508	0.0246	CbGeAlD
Apomorphine—CALY—lymph node—acquired immunodeficiency syndrome	0.00491	0.0238	CbGeAlD
Apomorphine—HTR2A—nerve—acquired immunodeficiency syndrome	0.00446	0.0216	CbGeAlD
Apomorphine—DRD5—lymphoid tissue—acquired immunodeficiency syndrome	0.00441	0.0213	CbGeAlD
Apomorphine—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.00396	0.0192	CbGeAlD
Apomorphine—DRD4—brain—acquired immunodeficiency syndrome	0.00391	0.0189	CbGeAlD
Apomorphine—HTR2A—endothelium—acquired immunodeficiency syndrome	0.0038	0.0184	CbGeAlD
Apomorphine—DRD3—nervous system—acquired immunodeficiency syndrome	0.00359	0.0174	CbGeAlD
Apomorphine—DRD3—central nervous system—acquired immunodeficiency syndrome	0.00346	0.0167	CbGeAlD
Apomorphine—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.00337	0.0163	CbGeAlD
Apomorphine—DRD5—nervous system—acquired immunodeficiency syndrome	0.00337	0.0163	CbGeAlD
Apomorphine—DRD5—central nervous system—acquired immunodeficiency syndrome	0.00324	0.0157	CbGeAlD
Apomorphine—HTR2B—skin of body—acquired immunodeficiency syndrome	0.00303	0.0147	CbGeAlD
Apomorphine—DRD2—retina—acquired immunodeficiency syndrome	0.0028	0.0135	CbGeAlD
Apomorphine—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.00276	0.0133	CbGeAlD
Apomorphine—DRD3—brain—acquired immunodeficiency syndrome	0.00275	0.0133	CbGeAlD
Apomorphine—ADRA1D—nervous system—acquired immunodeficiency syndrome	0.0027	0.0131	CbGeAlD
Apomorphine—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.00266	0.0129	CbGeAlD
Apomorphine—ADRA1D—central nervous system—acquired immunodeficiency syndrome	0.0026	0.0126	CbGeAlD
Apomorphine—DRD5—brain—acquired immunodeficiency syndrome	0.00257	0.0124	CbGeAlD
Apomorphine—DRD1—nervous system—acquired immunodeficiency syndrome	0.00257	0.0124	CbGeAlD
Apomorphine—DRD1—central nervous system—acquired immunodeficiency syndrome	0.00248	0.012	CbGeAlD
Apomorphine—HTR1B—spinal cord—acquired immunodeficiency syndrome	0.00247	0.012	CbGeAlD
Apomorphine—HTR2B—digestive system—acquired immunodeficiency syndrome	0.00243	0.0117	CbGeAlD
Apomorphine—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.00237	0.0115	CbGeAlD
Apomorphine—HTR2B—blood—acquired immunodeficiency syndrome	0.00231	0.0112	CbGeAlD
Apomorphine—Arthralgia—Nelfinavir—acquired immunodeficiency syndrome	0.00227	0.00418	CcSEcCtD
Apomorphine—Arthralgia—Stavudine—acquired immunodeficiency syndrome	0.00226	0.00417	CcSEcCtD
Apomorphine—Anxiety—Nelfinavir—acquired immunodeficiency syndrome	0.00226	0.00417	CcSEcCtD
Apomorphine—Anxiety—Stavudine—acquired immunodeficiency syndrome	0.00225	0.00415	CcSEcCtD
Apomorphine—Oedema—Nevirapine—acquired immunodeficiency syndrome	0.00224	0.00414	CcSEcCtD
Apomorphine—Back pain—Zidovudine—acquired immunodeficiency syndrome	0.00223	0.00411	CcSEcCtD
Apomorphine—Urinary tract infection—Ritonavir—acquired immunodeficiency syndrome	0.00223	0.00411	CcSEcCtD
Apomorphine—Arthralgia—Abacavir—acquired immunodeficiency syndrome	0.00223	0.0041	CcSEcCtD
Apomorphine—Pneumonia—Saquinavir—acquired immunodeficiency syndrome	0.00222	0.0041	CcSEcCtD
Apomorphine—Anxiety—Abacavir—acquired immunodeficiency syndrome	0.00222	0.00409	CcSEcCtD
Apomorphine—Hallucination—Delavirdine—acquired immunodeficiency syndrome	0.00222	0.00409	CcSEcCtD
Apomorphine—Oedema—Nelfinavir—acquired immunodeficiency syndrome	0.00217	0.00401	CcSEcCtD
Apomorphine—Flushing—Efavirenz—acquired immunodeficiency syndrome	0.00216	0.00399	CcSEcCtD
Apomorphine—Urinary tract infection—Saquinavir—acquired immunodeficiency syndrome	0.00215	0.00396	CcSEcCtD
Apomorphine—HTR2B—vagina—acquired immunodeficiency syndrome	0.00214	0.0104	CbGeAlD
Apomorphine—Oedema—Abacavir—acquired immunodeficiency syndrome	0.00213	0.00394	CcSEcCtD
Apomorphine—ADRA1B—brain—acquired immunodeficiency syndrome	0.00211	0.0102	CbGeAlD
Apomorphine—Hyperhidrosis—Nelfinavir—acquired immunodeficiency syndrome	0.0021	0.00387	CcSEcCtD
Apomorphine—Hyperhidrosis—Stavudine—acquired immunodeficiency syndrome	0.00209	0.00386	CcSEcCtD
Apomorphine—HTR1B—nervous system—acquired immunodeficiency syndrome	0.00208	0.0101	CbGeAlD
Apomorphine—Back pain—Indinavir—acquired immunodeficiency syndrome	0.00208	0.00383	CcSEcCtD
Apomorphine—Syncope—Zidovudine—acquired immunodeficiency syndrome	0.00207	0.00381	CcSEcCtD
Apomorphine—ADRA1D—brain—acquired immunodeficiency syndrome	0.00206	0.00998	CbGeAlD
Apomorphine—Hallucination—Ritonavir—acquired immunodeficiency syndrome	0.00205	0.00378	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.00204	0.00377	CcSEcCtD
Apomorphine—Loss of consciousness—Zidovudine—acquired immunodeficiency syndrome	0.00203	0.00374	CcSEcCtD
Apomorphine—HTR2B—lung—acquired immunodeficiency syndrome	0.00203	0.0098	CbGeAlD
Apomorphine—HTR1D—nervous system—acquired immunodeficiency syndrome	0.00202	0.00976	CbGeAlD
Apomorphine—HTR1B—central nervous system—acquired immunodeficiency syndrome	0.00201	0.00971	CbGeAlD
Apomorphine—HTR2C—nervous system—acquired immunodeficiency syndrome	0.002	0.00967	CbGeAlD
Apomorphine—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.002	0.00966	CbGeAlD
Apomorphine—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.00199	0.00368	CcSEcCtD
Apomorphine—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.00199	0.00368	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.00198	0.00365	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.00197	0.00364	CcSEcCtD
Apomorphine—Hallucination—Saquinavir—acquired immunodeficiency syndrome	0.00197	0.00364	CcSEcCtD
Apomorphine—DRD1—brain—acquired immunodeficiency syndrome	0.00197	0.00951	CbGeAlD
Apomorphine—Insomnia—Nelfinavir—acquired immunodeficiency syndrome	0.00197	0.00362	CcSEcCtD
Apomorphine—Chest pain—Zidovudine—acquired immunodeficiency syndrome	0.00196	0.00362	CcSEcCtD
Apomorphine—Arthralgia—Zidovudine—acquired immunodeficiency syndrome	0.00196	0.00362	CcSEcCtD
Apomorphine—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.00196	0.00362	CcSEcCtD
Apomorphine—Back pain—Efavirenz—acquired immunodeficiency syndrome	0.00196	0.00362	CcSEcCtD
Apomorphine—Insomnia—Stavudine—acquired immunodeficiency syndrome	0.00196	0.00361	CcSEcCtD
Apomorphine—Anxiety—Zidovudine—acquired immunodeficiency syndrome	0.00196	0.00361	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.00194	0.00359	CcSEcCtD
Apomorphine—HTR1D—central nervous system—acquired immunodeficiency syndrome	0.00194	0.0094	CbGeAlD
Apomorphine—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.00194	0.00357	CcSEcCtD
Apomorphine—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00194	0.00357	CcSEcCtD
Apomorphine—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.00193	0.00357	CcSEcCtD
Apomorphine—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.00193	0.00356	CcSEcCtD
Apomorphine—Insomnia—Abacavir—acquired immunodeficiency syndrome	0.00193	0.00356	CcSEcCtD
Apomorphine—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.00193	0.00355	CcSEcCtD
Apomorphine—Syncope—Indinavir—acquired immunodeficiency syndrome	0.00192	0.00355	CcSEcCtD
Apomorphine—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.00192	0.00931	CbGeAlD
Apomorphine—Flushing—Ritonavir—acquired immunodeficiency syndrome	0.00191	0.00353	CcSEcCtD
Apomorphine—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.0019	0.00351	CcSEcCtD
Apomorphine—Confusional state—Zidovudine—acquired immunodeficiency syndrome	0.0019	0.0035	CcSEcCtD
Apomorphine—Loss of consciousness—Indinavir—acquired immunodeficiency syndrome	0.00189	0.00348	CcSEcCtD
Apomorphine—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.00188	0.00347	CcSEcCtD
Apomorphine—HTR2B—nervous system—acquired immunodeficiency syndrome	0.00188	0.00908	CbGeAlD
Apomorphine—Back pain—Delavirdine—acquired immunodeficiency syndrome	0.00188	0.00346	CcSEcCtD
Apomorphine—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.00187	0.00345	CcSEcCtD
Apomorphine—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.00187	0.00344	CcSEcCtD
Apomorphine—Constipation—Stavudine—acquired immunodeficiency syndrome	0.00185	0.00342	CcSEcCtD
Apomorphine—Shock—Zidovudine—acquired immunodeficiency syndrome	0.00185	0.00342	CcSEcCtD
Apomorphine—Feeling abnormal—Nevirapine—acquired immunodeficiency syndrome	0.00185	0.00341	CcSEcCtD
Apomorphine—HTR2A—retina—acquired immunodeficiency syndrome	0.00185	0.00893	CbGeAlD
Apomorphine—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.00184	0.00339	CcSEcCtD
Apomorphine—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.00183	0.00337	CcSEcCtD
Apomorphine—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.00183	0.00337	CcSEcCtD
Apomorphine—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.00182	0.00336	CcSEcCtD
Apomorphine—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.00182	0.00336	CcSEcCtD
Apomorphine—ADRA2C—blood—acquired immunodeficiency syndrome	0.00182	0.0088	CbGeAlD
Apomorphine—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.00182	0.00335	CcSEcCtD
Apomorphine—HTR2B—central nervous system—acquired immunodeficiency syndrome	0.00181	0.00874	CbGeAlD
Apomorphine—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.00181	0.00333	CcSEcCtD
Apomorphine—Feeling abnormal—Nelfinavir—acquired immunodeficiency syndrome	0.00179	0.0033	CcSEcCtD
Apomorphine—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00179	0.0033	CcSEcCtD
Apomorphine—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.00178	0.00329	CcSEcCtD
Apomorphine—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00177	0.00326	CcSEcCtD
Apomorphine—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.00176	0.00324	CcSEcCtD
Apomorphine—ADRA2C—spinal cord—acquired immunodeficiency syndrome	0.00175	0.00848	CbGeAlD
Apomorphine—Oedema—Indinavir—acquired immunodeficiency syndrome	0.00175	0.00323	CcSEcCtD
Apomorphine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00174	0.00321	CcSEcCtD
Apomorphine—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.00174	0.00321	CcSEcCtD
Apomorphine—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.00174	0.0032	CcSEcCtD
Apomorphine—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.00173	0.0032	CcSEcCtD
Apomorphine—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.00173	0.00318	CcSEcCtD
Apomorphine—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.00173	0.00318	CcSEcCtD
Apomorphine—Shock—Indinavir—acquired immunodeficiency syndrome	0.00172	0.00318	CcSEcCtD
Apomorphine—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.00172	0.00317	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.00172	0.00316	CcSEcCtD
Apomorphine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00171	0.00316	CcSEcCtD
Apomorphine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00171	0.00315	CcSEcCtD
Apomorphine—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.0017	0.00314	CcSEcCtD
Apomorphine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.0017	0.00314	CcSEcCtD
Apomorphine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.00169	0.00312	CcSEcCtD
Apomorphine—ADRA2C—vagina—acquired immunodeficiency syndrome	0.00169	0.00816	CbGeAlD
Apomorphine—HTR1A—nervous system—acquired immunodeficiency syndrome	0.00168	0.00814	CbGeAlD
Apomorphine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00168	0.0031	CcSEcCtD
Apomorphine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00167	0.00309	CcSEcCtD
Apomorphine—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.00167	0.00308	CcSEcCtD
Apomorphine—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.00167	0.00308	CcSEcCtD
Apomorphine—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.00165	0.00304	CcSEcCtD
Apomorphine—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.00165	0.00304	CcSEcCtD
Apomorphine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.00165	0.00303	CcSEcCtD
Apomorphine—DRD2—lung—acquired immunodeficiency syndrome	0.00164	0.00794	CbGeAlD
Apomorphine—Shock—Efavirenz—acquired immunodeficiency syndrome	0.00163	0.003	CcSEcCtD
Apomorphine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00163	0.003	CcSEcCtD
Apomorphine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.00162	0.00299	CcSEcCtD
Apomorphine—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.00162	0.00783	CbGeAlD
Apomorphine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.00161	0.00297	CcSEcCtD
Apomorphine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00161	0.00297	CcSEcCtD
Apomorphine—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.00161	0.00297	CcSEcCtD
Apomorphine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.0016	0.00295	CcSEcCtD
Apomorphine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.0016	0.00294	CcSEcCtD
Apomorphine—ADRA2C—lung—acquired immunodeficiency syndrome	0.0016	0.00772	CbGeAlD
Apomorphine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.0016	0.00294	CcSEcCtD
Apomorphine—HTR1B—brain—acquired immunodeficiency syndrome	0.00159	0.00771	CbGeAlD
Apomorphine—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.00159	0.00294	CcSEcCtD
Apomorphine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00159	0.00293	CcSEcCtD
Apomorphine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00159	0.00293	CcSEcCtD
Apomorphine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.00158	0.00292	CcSEcCtD
Apomorphine—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.00158	0.00292	CcSEcCtD
Apomorphine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.00158	0.00291	CcSEcCtD
Apomorphine—Headache—Didanosine—acquired immunodeficiency syndrome	0.00156	0.00288	CcSEcCtD
Apomorphine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00156	0.00288	CcSEcCtD
Apomorphine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00156	0.00287	CcSEcCtD
Apomorphine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.00156	0.00287	CcSEcCtD
Apomorphine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00156	0.00287	CcSEcCtD
Apomorphine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00155	0.00287	CcSEcCtD
Apomorphine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00155	0.00286	CcSEcCtD
Apomorphine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.00155	0.00285	CcSEcCtD
Apomorphine—HTR1D—brain—acquired immunodeficiency syndrome	0.00154	0.00746	CbGeAlD
Apomorphine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00154	0.00283	CcSEcCtD
Apomorphine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00154	0.00283	CcSEcCtD
Apomorphine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00153	0.00283	CcSEcCtD
Apomorphine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00153	0.00282	CcSEcCtD
Apomorphine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00153	0.00282	CcSEcCtD
Apomorphine—HTR2C—brain—acquired immunodeficiency syndrome	0.00153	0.00739	CbGeAlD
Apomorphine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.00153	0.00282	CcSEcCtD
Apomorphine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00153	0.00282	CcSEcCtD
Apomorphine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.00152	0.00281	CcSEcCtD
Apomorphine—DRD2—nervous system—acquired immunodeficiency syndrome	0.00152	0.00735	CbGeAlD
Apomorphine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.00152	0.0028	CcSEcCtD
Apomorphine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00151	0.00278	CcSEcCtD
Apomorphine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00151	0.00278	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00151	0.00278	CcSEcCtD
Apomorphine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.0015	0.00276	CcSEcCtD
Apomorphine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.0015	0.00276	CcSEcCtD
Apomorphine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00149	0.00274	CcSEcCtD
Apomorphine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00148	0.00273	CcSEcCtD
Apomorphine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00148	0.00273	CcSEcCtD
Apomorphine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00148	0.00273	CcSEcCtD
Apomorphine—ADRA2C—nervous system—acquired immunodeficiency syndrome	0.00148	0.00715	CbGeAlD
Apomorphine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.00148	0.00272	CcSEcCtD
Apomorphine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.00148	0.00272	CcSEcCtD
Apomorphine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00148	0.00272	CcSEcCtD
Apomorphine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00147	0.00271	CcSEcCtD
Apomorphine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.00147	0.00271	CcSEcCtD
Apomorphine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.00147	0.00271	CcSEcCtD
Apomorphine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.00146	0.0027	CcSEcCtD
Apomorphine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.00146	0.0027	CcSEcCtD
Apomorphine—DRD2—central nervous system—acquired immunodeficiency syndrome	0.00146	0.00708	CbGeAlD
Apomorphine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00146	0.00269	CcSEcCtD
Apomorphine—ADRA2A—blood—acquired immunodeficiency syndrome	0.00145	0.00702	CbGeAlD
Apomorphine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.00145	0.00267	CcSEcCtD
Apomorphine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00144	0.00266	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00144	0.00266	CcSEcCtD
Apomorphine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.00144	0.00266	CcSEcCtD
Apomorphine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00144	0.00265	CcSEcCtD
Apomorphine—HTR2B—brain—acquired immunodeficiency syndrome	0.00143	0.00694	CbGeAlD
Apomorphine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00143	0.00264	CcSEcCtD
Apomorphine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00143	0.00264	CcSEcCtD
Apomorphine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00143	0.00263	CcSEcCtD
Apomorphine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00143	0.00263	CcSEcCtD
Apomorphine—ADRA2C—central nervous system—acquired immunodeficiency syndrome	0.00142	0.00688	CbGeAlD
Apomorphine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.00142	0.00262	CcSEcCtD
Apomorphine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00142	0.00261	CcSEcCtD
Apomorphine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00141	0.00261	CcSEcCtD
Apomorphine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00141	0.0026	CcSEcCtD
Apomorphine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00141	0.0026	CcSEcCtD
Apomorphine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00141	0.0026	CcSEcCtD
Apomorphine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00141	0.00259	CcSEcCtD
Apomorphine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00141	0.00259	CcSEcCtD
Apomorphine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.0014	0.00259	CcSEcCtD
Apomorphine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.0014	0.00259	CcSEcCtD
Apomorphine—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.0014	0.00677	CbGeAlD
Apomorphine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.0014	0.00258	CcSEcCtD
Apomorphine—HTR2B—lymph node—acquired immunodeficiency syndrome	0.00139	0.00671	CbGeAlD
Apomorphine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.00139	0.00256	CcSEcCtD
Apomorphine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00138	0.00255	CcSEcCtD
Apomorphine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00138	0.00254	CcSEcCtD
Apomorphine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00137	0.00252	CcSEcCtD
Apomorphine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.00136	0.00252	CcSEcCtD
Apomorphine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.00136	0.00251	CcSEcCtD
Apomorphine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.00136	0.00251	CcSEcCtD
Apomorphine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00136	0.00251	CcSEcCtD
Apomorphine—Headache—Stavudine—acquired immunodeficiency syndrome	0.00136	0.0025	CcSEcCtD
Apomorphine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00136	0.0025	CcSEcCtD
Apomorphine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.00136	0.0025	CcSEcCtD
Apomorphine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00135	0.0025	CcSEcCtD
Apomorphine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00135	0.00249	CcSEcCtD
Apomorphine—ADRA2A—vagina—acquired immunodeficiency syndrome	0.00135	0.00651	CbGeAlD
Apomorphine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.00134	0.00248	CcSEcCtD
Apomorphine—Headache—Abacavir—acquired immunodeficiency syndrome	0.00134	0.00247	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00133	0.00246	CcSEcCtD
Apomorphine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00133	0.00246	CcSEcCtD
Apomorphine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00133	0.00246	CcSEcCtD
Apomorphine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.00132	0.00244	CcSEcCtD
Apomorphine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.00132	0.00244	CcSEcCtD
Apomorphine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00132	0.00243	CcSEcCtD
Apomorphine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00131	0.00241	CcSEcCtD
Apomorphine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.0013	0.00241	CcSEcCtD
Apomorphine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.0013	0.0024	CcSEcCtD
Apomorphine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.0013	0.0024	CcSEcCtD
Apomorphine—HTR2A—digestive system—acquired immunodeficiency syndrome	0.0013	0.00627	CbGeAlD
Apomorphine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00129	0.00238	CcSEcCtD
Apomorphine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00129	0.00238	CcSEcCtD
Apomorphine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00129	0.00237	CcSEcCtD
Apomorphine—HTR1A—brain—acquired immunodeficiency syndrome	0.00129	0.00622	CbGeAlD
Apomorphine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00128	0.00237	CcSEcCtD
Apomorphine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.00127	0.00235	CcSEcCtD
Apomorphine—ADRA2A—lung—acquired immunodeficiency syndrome	0.00127	0.00616	CbGeAlD
Apomorphine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00127	0.00234	CcSEcCtD
Apomorphine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.00126	0.00233	CcSEcCtD
Apomorphine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00126	0.00232	CcSEcCtD
Apomorphine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00126	0.00232	CcSEcCtD
Apomorphine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00126	0.00232	CcSEcCtD
Apomorphine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.00125	0.00231	CcSEcCtD
Apomorphine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.00125	0.00231	CcSEcCtD
Apomorphine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00125	0.0023	CcSEcCtD
Apomorphine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00124	0.00228	CcSEcCtD
Apomorphine—HTR2A—blood—acquired immunodeficiency syndrome	0.00123	0.00597	CbGeAlD
Apomorphine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00122	0.00226	CcSEcCtD
Apomorphine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.00122	0.00224	CcSEcCtD
Apomorphine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.00121	0.00224	CcSEcCtD
Apomorphine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.00121	0.00222	CcSEcCtD
Apomorphine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.0012	0.00222	CcSEcCtD
Apomorphine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.0012	0.00221	CcSEcCtD
Apomorphine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.0012	0.00221	CcSEcCtD
Apomorphine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.0012	0.00221	CcSEcCtD
Apomorphine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.00119	0.0022	CcSEcCtD
Apomorphine—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.00119	0.00575	CbGeAlD
Apomorphine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00119	0.00219	CcSEcCtD
Apomorphine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00118	0.00217	CcSEcCtD
Apomorphine—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.00118	0.0057	CbGeAlD
Apomorphine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00117	0.00216	CcSEcCtD
Apomorphine—DRD2—brain—acquired immunodeficiency syndrome	0.00116	0.00562	CbGeAlD
Apomorphine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00116	0.00214	CcSEcCtD
Apomorphine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.00116	0.00214	CcSEcCtD
Apomorphine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00116	0.00214	CcSEcCtD
Apomorphine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00115	0.00212	CcSEcCtD
Apomorphine—HTR2A—vagina—acquired immunodeficiency syndrome	0.00114	0.00554	CbGeAlD
Apomorphine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.00114	0.00209	CcSEcCtD
Apomorphine—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.00113	0.00549	CbGeAlD
Apomorphine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00113	0.00209	CcSEcCtD
Apomorphine—ADRA2C—brain—acquired immunodeficiency syndrome	0.00113	0.00546	CbGeAlD
Apomorphine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00112	0.00207	CcSEcCtD
Apomorphine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00112	0.00206	CcSEcCtD
Apomorphine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00111	0.00205	CcSEcCtD
Apomorphine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00111	0.00204	CcSEcCtD
Apomorphine—Headache—Indinavir—acquired immunodeficiency syndrome	0.0011	0.00202	CcSEcCtD
Apomorphine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00109	0.00202	CcSEcCtD
Apomorphine—ADRA2C—lymph node—acquired immunodeficiency syndrome	0.00109	0.00528	CbGeAlD
Apomorphine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00108	0.002	CcSEcCtD
Apomorphine—HTR2A—lung—acquired immunodeficiency syndrome	0.00108	0.00524	CbGeAlD
Apomorphine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00105	0.00194	CcSEcCtD
Apomorphine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00105	0.00194	CcSEcCtD
Apomorphine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00105	0.00193	CcSEcCtD
Apomorphine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00104	0.00192	CcSEcCtD
Apomorphine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00104	0.00191	CcSEcCtD
Apomorphine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00104	0.00191	CcSEcCtD
Apomorphine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00101	0.00186	CcSEcCtD
Apomorphine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00101	0.00186	CcSEcCtD
Apomorphine—HTR2A—nervous system—acquired immunodeficiency syndrome	0.001	0.00485	CbGeAlD
Apomorphine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.001	0.00185	CcSEcCtD
Apomorphine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000997	0.00184	CcSEcCtD
Apomorphine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000992	0.00183	CcSEcCtD
Apomorphine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000983	0.00181	CcSEcCtD
Apomorphine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000968	0.00178	CcSEcCtD
Apomorphine—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000965	0.00467	CbGeAlD
Apomorphine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000964	0.00178	CcSEcCtD
Apomorphine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000964	0.00178	CcSEcCtD
Apomorphine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000951	0.00175	CcSEcCtD
Apomorphine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00094	0.00173	CcSEcCtD
Apomorphine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000932	0.00172	CcSEcCtD
Apomorphine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000931	0.00172	CcSEcCtD
Apomorphine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00092	0.0017	CcSEcCtD
Apomorphine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000917	0.00169	CcSEcCtD
Apomorphine—ADRA2A—brain—acquired immunodeficiency syndrome	0.000901	0.00436	CbGeAlD
Apomorphine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000896	0.00165	CcSEcCtD
Apomorphine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000889	0.00164	CcSEcCtD
Apomorphine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000883	0.00163	CcSEcCtD
Apomorphine—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000871	0.00421	CbGeAlD
Apomorphine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00087	0.0016	CcSEcCtD
Apomorphine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000855	0.00158	CcSEcCtD
Apomorphine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000842	0.00155	CcSEcCtD
Apomorphine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000837	0.00154	CcSEcCtD
Apomorphine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000798	0.00147	CcSEcCtD
Apomorphine—HTR2A—brain—acquired immunodeficiency syndrome	0.000766	0.00371	CbGeAlD
Apomorphine—ADRA2B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000106	0.000424	CbGpPWpGaD
Apomorphine—HTR2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000105	0.000419	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000105	0.000418	CbGpPWpGaD
Apomorphine—HTR1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000104	0.000416	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000104	0.000415	CbGpPWpGaD
Apomorphine—HTR2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000104	0.000413	CbGpPWpGaD
Apomorphine—HTR1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000103	0.000409	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000103	0.000409	CbGpPWpGaD
Apomorphine—ADRA2C—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000102	0.000408	CbGpPWpGaD
Apomorphine—HTR2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000102	0.000407	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000101	0.000403	CbGpPWpGaD
Apomorphine—ADRA2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000101	0.000402	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000101	0.000401	CbGpPWpGaD
Apomorphine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	9.96e-05	0.000397	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	9.95e-05	0.000396	CbGpPWpGaD
Apomorphine—ADRA2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	9.94e-05	0.000396	CbGpPWpGaD
Apomorphine—ADRA1B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	9.93e-05	0.000396	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.92e-05	0.000395	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.92e-05	0.000395	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.92e-05	0.000395	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.86e-05	0.000393	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.86e-05	0.000393	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	9.81e-05	0.000391	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.79e-05	0.00039	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.79e-05	0.00039	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.79e-05	0.00039	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	9.78e-05	0.00039	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	9.78e-05	0.00039	CbGpPWpGaD
Apomorphine—ADRA1B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	9.78e-05	0.00039	CbGpPWpGaD
Apomorphine—ADRA2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	9.73e-05	0.000388	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	9.66e-05	0.000385	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.65e-05	0.000385	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.65e-05	0.000385	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.64e-05	0.000384	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.64e-05	0.000384	CbGpPWpGaD
Apomorphine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	9.53e-05	0.00038	CbGpPWpGaD
Apomorphine—DRD5—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.5e-05	0.000379	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.5e-05	0.000379	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.5e-05	0.000379	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	9.47e-05	0.000377	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	9.42e-05	0.000375	CbGpPWpGaD
Apomorphine—HTR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	9.39e-05	0.000374	CbGpPWpGaD
Apomorphine—HTR2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	9.35e-05	0.000372	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	9.33e-05	0.000372	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	9.28e-05	0.00037	CbGpPWpGaD
Apomorphine—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	9.28e-05	0.00037	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	9.16e-05	0.000365	CbGpPWpGaD
Apomorphine—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	9.16e-05	0.000365	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.09e-05	0.000362	CbGpPWpGaD
Apomorphine—ADRA2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	9.09e-05	0.000362	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.07e-05	0.000361	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.07e-05	0.000361	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	9.03e-05	0.00036	CbGpPWpGaD
Apomorphine—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	9.02e-05	0.000359	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	9.02e-05	0.000359	CbGpPWpGaD
Apomorphine—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	9.01e-05	0.000359	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.97e-05	0.000358	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.97e-05	0.000358	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	8.96e-05	0.000357	CbGpPWpGaD
Apomorphine—ADRA1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	8.95e-05	0.000357	CbGpPWpGaD
Apomorphine—ADRA2B—Hemostasis—IL2—acquired immunodeficiency syndrome	8.9e-05	0.000355	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	8.88e-05	0.000354	CbGpPWpGaD
Apomorphine—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8.87e-05	0.000354	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	8.84e-05	0.000352	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.82e-05	0.000351	CbGpPWpGaD
Apomorphine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	8.65e-05	0.000345	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	8.65e-05	0.000345	CbGpPWpGaD
Apomorphine—DRD5—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.63e-05	0.000344	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	8.6e-05	0.000343	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.55e-05	0.000341	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.55e-05	0.000341	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	8.53e-05	0.00034	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	8.49e-05	0.000338	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.44e-05	0.000336	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.44e-05	0.000336	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.44e-05	0.000336	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.44e-05	0.000336	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	8.37e-05	0.000333	CbGpPWpGaD
Apomorphine—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	8.32e-05	0.000332	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	8.31e-05	0.000331	CbGpPWpGaD
Apomorphine—ADRA2C—Hemostasis—IL2—acquired immunodeficiency syndrome	8.31e-05	0.000331	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	8.25e-05	0.000329	CbGpPWpGaD
Apomorphine—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	8.25e-05	0.000329	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	8.24e-05	0.000328	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	8.2e-05	0.000327	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	8.19e-05	0.000326	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	8.18e-05	0.000326	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	8.12e-05	0.000324	CbGpPWpGaD
Apomorphine—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	8.12e-05	0.000323	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.1e-05	0.000323	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8.07e-05	0.000322	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	8.06e-05	0.000321	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	7.82e-05	0.000312	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	7.78e-05	0.00031	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.62e-05	0.000304	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.62e-05	0.000304	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7.59e-05	0.000303	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	7.57e-05	0.000302	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.5e-05	0.000299	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.49e-05	0.000298	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7.47e-05	0.000298	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	7.45e-05	0.000297	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	7.44e-05	0.000297	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.39e-05	0.000294	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	7.38e-05	0.000294	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.37e-05	0.000294	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.35e-05	0.000293	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.35e-05	0.000293	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.34e-05	0.000293	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	7.33e-05	0.000292	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.31e-05	0.000292	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.31e-05	0.000292	CbGpPWpGaD
Apomorphine—HTR1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.28e-05	0.00029	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.23e-05	0.000288	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.23e-05	0.000288	CbGpPWpGaD
Apomorphine—HTR1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.13e-05	0.000284	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.12e-05	0.000284	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7.11e-05	0.000284	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7.11e-05	0.000284	CbGpPWpGaD
Apomorphine—DRD4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.01e-05	0.000279	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	7e-05	0.000279	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	7e-05	0.000279	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.9e-05	0.000275	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.87e-05	0.000274	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	6.8e-05	0.000271	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.79e-05	0.000271	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.76e-05	0.000269	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.76e-05	0.000269	CbGpPWpGaD
Apomorphine—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	6.75e-05	0.000269	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	6.7e-05	0.000267	CbGpPWpGaD
Apomorphine—HTR2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.69e-05	0.000267	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.62e-05	0.000264	CbGpPWpGaD
Apomorphine—HTR1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.61e-05	0.000263	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.51e-05	0.000259	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.5e-05	0.000259	CbGpPWpGaD
Apomorphine—HTR1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.47e-05	0.000258	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.46e-05	0.000257	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.46e-05	0.000257	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.42e-05	0.000256	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.42e-05	0.000256	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.41e-05	0.000255	CbGpPWpGaD
Apomorphine—DRD4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.37e-05	0.000254	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.35e-05	0.000253	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.35e-05	0.000253	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.32e-05	0.000252	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.32e-05	0.000252	CbGpPWpGaD
Apomorphine—DRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.31e-05	0.000252	CbGpPWpGaD
Apomorphine—DRD3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.23e-05	0.000248	CbGpPWpGaD
Apomorphine—ADRA1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.23e-05	0.000248	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.21e-05	0.000248	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.15e-05	0.000245	CbGpPWpGaD
Apomorphine—HTR2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.08e-05	0.000242	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.86e-05	0.000234	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.79e-05	0.000231	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.78e-05	0.00023	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.78e-05	0.00023	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	5.78e-05	0.00023	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	5.78e-05	0.00023	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.73e-05	0.000228	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.71e-05	0.000227	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.66e-05	0.000225	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.66e-05	0.000225	CbGpPWpGaD
Apomorphine—ADRA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.62e-05	0.000224	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.59e-05	0.000223	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.56e-05	0.000222	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.51e-05	0.00022	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.48e-05	0.000218	CbGpPWpGaD
Apomorphine—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.43e-05	0.000216	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.41e-05	0.000216	CbGpPWpGaD
Apomorphine—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.4e-05	0.000215	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.33e-05	0.000212	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.33e-05	0.000212	CbGpPWpGaD
Apomorphine—ADRA2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.25e-05	0.000209	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.25e-05	0.000209	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.22e-05	0.000208	CbGpPWpGaD
Apomorphine—ADRA1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.17e-05	0.000206	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.11e-05	0.000203	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.1e-05	0.000203	CbGpPWpGaD
Apomorphine—DRD5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.07e-05	0.000202	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.04e-05	0.000201	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.01e-05	0.0002	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.93e-05	0.000196	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.91e-05	0.000196	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.9e-05	0.000195	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.88e-05	0.000194	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.84e-05	0.000193	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.83e-05	0.000193	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.8e-05	0.000191	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.77e-05	0.00019	CbGpPWpGaD
Apomorphine—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.77e-05	0.00019	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.76e-05	0.00019	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.69e-05	0.000187	CbGpPWpGaD
Apomorphine—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.69e-05	0.000187	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.42e-05	0.000176	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.4e-05	0.000175	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.35e-05	0.000173	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.33e-05	0.000173	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.33e-05	0.000172	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.27e-05	0.00017	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.26e-05	0.00017	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—ALB—acquired immunodeficiency syndrome	4.16e-05	0.000166	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.96e-05	0.000158	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.9e-05	0.000156	CbGpPWpGaD
Apomorphine—HTR1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.88e-05	0.000155	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.87e-05	0.000154	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.82e-05	0.000152	CbGpPWpGaD
Apomorphine—HTR1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.8e-05	0.000152	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.76e-05	0.00015	CbGpPWpGaD
Apomorphine—DRD4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.74e-05	0.000149	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.59e-05	0.000143	CbGpPWpGaD
Apomorphine—HTR2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.57e-05	0.000142	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.39e-05	0.000135	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	3.38e-05	0.000135	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.37e-05	0.000134	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.34e-05	0.000133	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.34e-05	0.000133	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.32e-05	0.000132	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.32e-05	0.000132	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.02e-05	0.00012	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3e-05	0.00012	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3e-05	0.000119	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.91e-05	0.000116	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.9e-05	0.000115	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.9e-05	0.000115	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.88e-05	0.000115	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.82e-05	0.000112	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.8e-05	0.000112	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.77e-05	0.000111	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.76e-05	0.00011	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.56e-05	0.000102	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.54e-05	0.000101	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.52e-05	0.0001	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.5e-05	9.97e-05	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.29e-05	9.14e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.29e-05	9.12e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.28e-05	9.07e-05	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.25e-05	8.95e-05	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.21e-05	8.81e-05	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.11e-05	8.41e-05	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.99e-05	7.93e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.96e-05	7.83e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.96e-05	7.83e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.77e-05	7.07e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.71e-05	6.82e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.7e-05	6.79e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.66e-05	6.6e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.63e-05	6.5e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.5e-05	5.99e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.48e-05	5.89e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.35e-05	5.36e-05	CbGpPWpGaD
